Connect Biopharma Holdings Stock Technical Analysis
| CNTB Stock | USD 1.37 0.02 1.44% |
As of the 24th of April, Connect Biopharma shows the Downside Deviation of 7.59, mean deviation of 6.75, and Risk Adjusted Performance of 0.0653. Connect Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Connect Biopharma Holdings, which can be compared to its peers. Please confirm Connect Biopharma jensen alpha, as well as the relationship between the potential upside and skewness to decide if Connect Biopharma is priced correctly, providing market reflects its regular price of 1.37 per share. Given that Connect Biopharma is a hitting penny stock territory we recommend to closely look at its total risk alpha.
Connect Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Connect, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ConnectConnect |
Connect Biopharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 6.0 | Strong Buy | 2 | Odds |
Most Connect analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Connect stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Connect Biopharma, talking to its executives and customers, or listening to Connect conference calls.
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Connect Biopharma Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Connect Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Connect Biopharma Trend Analysis
Use this graph to draw trend lines for Connect Biopharma Holdings. You can use it to identify possible trend reversals for Connect Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Connect Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Connect Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Connect Biopharma Holdings applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Connect Biopharma Holdings will continue generating value for investors. It has 122 observation points and a regression sum of squares at 5.03, which is the sum of squared deviations for the predicted Connect Biopharma price change compared to its average price change.About Connect Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Connect Biopharma Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Connect Biopharma Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Connect Biopharma price pattern first instead of the macroeconomic environment surrounding Connect Biopharma. By analyzing Connect Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Connect Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Connect Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 (projected) | Net Debt To EBITDA | 0.72 | 0.83 | 1.41 | Intangibles To Total Assets | 0.0182 | 4.92E-4 | 4.68E-4 |
Connect Biopharma April 24, 2024 Technical Indicators
Most technical analysis of Connect help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Connect from various momentum indicators to cycle indicators. When you analyze Connect charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0653 | |||
| Market Risk Adjusted Performance | 0.6959 | |||
| Mean Deviation | 6.75 | |||
| Semi Deviation | 7.09 | |||
| Downside Deviation | 7.59 | |||
| Coefficient Of Variation | 1113.06 | |||
| Standard Deviation | 9.05 | |||
| Variance | 81.83 | |||
| Information Ratio | 0.0793 | |||
| Jensen Alpha | 0.7029 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0945 | |||
| Treynor Ratio | 0.6859 | |||
| Maximum Drawdown | 42.32 | |||
| Value At Risk | (12.34) | |||
| Potential Upside | 18.89 | |||
| Downside Variance | 57.63 | |||
| Semi Variance | 50.21 | |||
| Expected Short fall | (8.24) | |||
| Skewness | 0.7573 | |||
| Kurtosis | 0.9102 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Connect Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Connect Biopharma. If investors know Connect will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Connect Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (0.27) | Return On Equity (0.46) |
The market value of Connect Biopharma is measured differently than its book value, which is the value of Connect that is recorded on the company's balance sheet. Investors also form their own opinion of Connect Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Connect Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Connect Biopharma's market value can be influenced by many factors that don't directly affect Connect Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Connect Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Connect Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Connect Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.